IOM Committee Members Respond to Endocrine Society Vitamin D Guideline
IOM Committee Members Respond to Endocrine Society Vitamin D Guideline
复制标题
DOI：
10.1210/jc.2011-2218
复制
发表时间：
2012-04-01
影响因子：
5.8
通讯作者：
Taylor, Christine L.
中科院分区：
文献类型：
--
作者：
Rosen, Clifford J.;Abrams, Steven A.;Taylor, Christine L.
2011 年初，医学研究所召集的一个委员会发布了一份关于钙和维生素 D 膳食参考摄入量的报告。内分泌学会工作组于 2011 年 7 月发布了评估、治疗和预防维生素 D 缺乏症的指南。尽管这些报告的目的不同，但关于可用数据的性质和得出的结论的分歧给临床医生、研究人员和公众造成了困惑。在这篇评论中，医学研究所委员会的成员对内分泌学会指南中未得到充分支持且需要重新考虑的方面做出了回应。这些担忧集中在目标血清 25-羟基维生素 D 水平、维生素 D 缺乏症的定义以及谁构成高危人群与普通人群的问题。 (临床内分泌代谢杂志 97: 1146-1152, 2012)
In early 2011, a committee convened by the Institute of Medicine issued a report on the Dietary Reference Intakes for calcium and vitamin D. The Endocrine Society Task Force in July 2011 published a guideline for the evaluation, treatment, and prevention of vitamin D deficiency. Although these reports are intended for different purposes, the disagreements concerning the nature of the available data and the resulting conclusions have caused confusion for clinicians, researchers, and the public. In this commentary, members of the Institute of Medicine committee respond to aspects of The Endocrine Society guideline that are not well supported and in need of reconsideration. These concerns focus on target serum 25-hydroxyvitamin D levels, the definition of vitamin D deficiency, and the question of who constitutes a population at risk vs. the general population. (J Clin Endocrinol Metab 97: 1146-1152, 2012)